Hofseth BioCare ASA
Simbol: HBC.OL
OSL
2.01
NOKTržna cena danes
-8.4297
Razmerje P/E
-0.2706
Razmerje PEG
794.11M
Kapaciteta MRK
- 0.00%
Donos DIV
Hofseth BioCare ASA (HBC-OL) Finančni izkazi
Bilanca stanja
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 80.44 | 23.9 | 29.9 | 47.2 | ||||||||||||||
balance-sheet.row.short-term-investments | -2 | 0 | -1 | 0 | ||||||||||||||
balance-sheet.row.net-receivables | 72.92 | 14.8 | 14.1 | 32.3 | ||||||||||||||
balance-sheet.row.inventory | 377.95 | 82.5 | 116.5 | 90.8 | ||||||||||||||
balance-sheet.row.other-current-assets | 42.54 | 9.7 | 12.7 | 0 | ||||||||||||||
balance-sheet.row.total-current-assets | 573.85 | 131 | 175.7 | 170.3 | ||||||||||||||
balance-sheet.row.property-plant-equipment-net | 643.32 | 165.7 | 168.8 | 185.8 | ||||||||||||||
balance-sheet.row.goodwill | 0 | 0 | 0 | 0 | ||||||||||||||
balance-sheet.row.intangible-assets | 223.12 | 55.3 | 60.6 | 53.1 | ||||||||||||||
balance-sheet.row.goodwill-and-intangible-assets | 223.12 | 55.3 | 60.6 | 53.1 | ||||||||||||||
balance-sheet.row.long-term-investments | 153.49 | 38.1 | 6.9 | 6.8 | ||||||||||||||
balance-sheet.row.tax-assets | -131.91 | 0 | -6.9 | -6.8 | ||||||||||||||
balance-sheet.row.other-non-current-assets | 131.91 | 0 | 5.9 | 6.7 | ||||||||||||||
balance-sheet.row.total-non-current-assets | 1019.92 | 259.1 | 235.3 | 245.7 | ||||||||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | ||||||||||||||
balance-sheet.row.total-assets | 1593.77 | 390.1 | 411 | 416 | ||||||||||||||
balance-sheet.row.account-payables | 504.95 | 55.2 | 145.8 | 124.2 | ||||||||||||||
balance-sheet.row.short-term-debt | 129.73 | 39.7 | 13.4 | 14.5 | ||||||||||||||
balance-sheet.row.tax-payables | 0 | 0 | 0 | 0 | ||||||||||||||
balance-sheet.row.long-term-debt-total | 370.49 | 97.1 | 90.8 | 124.7 | ||||||||||||||
Deferred Revenue Non Current | 0 | 0 | 0 | 0 | ||||||||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 0 | - | - | - | ||||||||||||||
balance-sheet.row.other-current-liab | 181.07 | 157 | 13.1 | 12.2 | ||||||||||||||
balance-sheet.row.total-non-current-liabilities | 370.48 | 97.1 | 90.8 | 124.7 | ||||||||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | ||||||||||||||
balance-sheet.row.capital-lease-obligations | 107.63 | 96.8 | 102.8 | 113 | ||||||||||||||
balance-sheet.row.total-liab | 1186.24 | 349 | 263 | 275.6 | ||||||||||||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 0 | ||||||||||||||
balance-sheet.row.common-stock | 15.97 | 4 | 4 | 3.6 | ||||||||||||||
balance-sheet.row.retained-earnings | 394.32 | 37.9 | 145.7 | 0 | ||||||||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 0 | 0 | 0 | 0 | ||||||||||||||
balance-sheet.row.other-total-stockholders-equity | 0 | 0 | -1 | 137.5 | ||||||||||||||
balance-sheet.row.total-stockholders-equity | 410.29 | 41.8 | 148.7 | 141.1 | ||||||||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 1593.77 | 390.1 | 411 | 416 | ||||||||||||||
balance-sheet.row.minority-interest | -2.75 | -0.7 | -0.7 | -0.7 | ||||||||||||||
balance-sheet.row.total-equity | 407.54 | 41.1 | 148 | 140.4 | ||||||||||||||
balance-sheet.row.total-liabilities-and-total-equity | 1593.77 | - | - | - | ||||||||||||||
Total Investments | 151.49 | 38.1 | 5.9 | 6.8 | ||||||||||||||
balance-sheet.row.total-debt | 500.22 | 136.8 | 104.2 | 139.2 | ||||||||||||||
balance-sheet.row.net-debt | 419.78 | 112.9 | 74.3 | 92 |
Izkaz denarnih tokov
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | -97.85 | -106.7 | -137.4 | -126.5 | ||||||||||||||
cash-flows.row.depreciation-and-amortization | 37.19 | 36.4 | 30.4 | 29.4 | ||||||||||||||
cash-flows.row.deferred-income-tax | 0 | 0 | 0 | 0 | ||||||||||||||
cash-flows.row.stock-based-compensation | 0 | 0 | 0 | 0 | ||||||||||||||
cash-flows.row.change-in-working-capital | 46.07 | 77.4 | 52.1 | 26 | ||||||||||||||
cash-flows.row.account-receivables | -7.54 | -0.8 | -4 | 4.2 | ||||||||||||||
cash-flows.row.inventory | 25.04 | 34 | -25.7 | -17.5 | ||||||||||||||
cash-flows.row.account-payables | 34.86 | 53.4 | 21.6 | 39.2 | ||||||||||||||
cash-flows.row.other-working-capital | -6.29 | -9.2 | 60.2 | 0.1 | ||||||||||||||
cash-flows.row.other-non-cash-items | 4.04 | -24.5 | 9.8 | 9.4 | ||||||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | -32.98 | 0 | 0 | 0 | ||||||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | -20.82 | -23.7 | -17.8 | -37.8 | ||||||||||||||
cash-flows.row.acquisitions-net | 0.69 | 0 | 0 | -0.2 | ||||||||||||||
cash-flows.row.purchases-of-investments | -1.61 | 0 | 0 | -0.2 | ||||||||||||||
cash-flows.row.sales-maturities-of-investments | 0 | 0 | 0 | 0 | ||||||||||||||
cash-flows.row.other-investing-activites | 0 | 0 | 0 | 0.2 | ||||||||||||||
cash-flows.row.net-cash-used-for-investing-activites | -20.82 | -23.7 | -17.8 | -37.9 | ||||||||||||||
cash-flows.row.debt-repayment | -72.34 | -32.6 | -2.4 | -3.4 | ||||||||||||||
cash-flows.row.common-stock-issued | -0.51 | -0.2 | 70.8 | 0 | ||||||||||||||
cash-flows.row.common-stock-repurchased | 0 | 0 | 0 | 0 | ||||||||||||||
cash-flows.row.dividends-paid | 0 | 0 | 0 | 0 | ||||||||||||||
cash-flows.row.other-financing-activites | -4.82 | 0 | -22.9 | -19.8 | ||||||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | 53.11 | 32.4 | 45.5 | -23.2 | ||||||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | 0 | 0 | 0 | 0 | ||||||||||||||
cash-flows.row.net-change-in-cash | -0.7 | -8.5 | -17.5 | -122.9 | ||||||||||||||
cash-flows.row.cash-at-end-of-period | 80.44 | 23.9 | 32.4 | 49.9 | ||||||||||||||
cash-flows.row.cash-at-beginning-of-period | 81.14 | 32.4 | 49.9 | 172.8 | ||||||||||||||
cash-flows.row.operating-cash-flow | -32.98 | -17.3 | -45.2 | -61.8 | ||||||||||||||
cash-flows.row.capital-expenditure | -20.82 | -23.7 | -17.8 | -37.8 | ||||||||||||||
cash-flows.row.free-cash-flow | -53.81 | -40.9 | -62.9 | -99.5 |
Vrstica izkaza poslovnega izida
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 200.66 | 190.8 | 120.4 | 87.6 | ||||||||||||||
income-statement-row.row.cost-of-revenue | 190.79 | 245.4 | 91.9 | 64.5 | ||||||||||||||
income-statement-row.row.gross-profit | 9.88 | -54.6 | 28.5 | 23.1 | ||||||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | ||||||||||||||
income-statement-row.row.research-development | 1.25 | - | - | - | ||||||||||||||
income-statement-row.row.selling-general-administrative | 0 | - | - | - | ||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | ||||||||||||||
income-statement-row.row.other-expenses | 4.08 | -6.1 | 1.6 | 0 | ||||||||||||||
income-statement-row.row.operating-expenses | 126.79 | 71.6 | 157.1 | 141.7 | ||||||||||||||
income-statement-row.row.cost-and-expenses | 317.58 | 317 | 249.1 | 206.2 | ||||||||||||||
income-statement-row.row.interest-income | 2.33 | 0.6 | 0.7 | 0.6 | ||||||||||||||
income-statement-row.row.interest-expense | 8.52 | 7.5 | 10 | 9.4 | ||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | ||||||||||||||
income-statement-row.row.total-other-income-expensenet | -6.82 | 16.9 | -8.8 | -7.9 | ||||||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | ||||||||||||||
income-statement-row.row.other-operating-expenses | 4.08 | -6.1 | 1.6 | 0 | ||||||||||||||
income-statement-row.row.total-operating-expenses | -6.82 | 16.9 | -8.8 | -7.9 | ||||||||||||||
income-statement-row.row.interest-expense | 8.52 | 7.5 | 10 | 9.4 | ||||||||||||||
income-statement-row.row.depreciation-and-amortization | 37.19 | 36.4 | 30.4 | 29.4 | ||||||||||||||
income-statement-row.row.ebitda-caps | -50.58 | - | - | - | ||||||||||||||
income-statement-row.row.operating-income | -87.74 | -126.2 | -128.6 | -118.6 | ||||||||||||||
income-statement-row.row.income-before-tax | -94.56 | -109.2 | -137.4 | -126.5 | ||||||||||||||
income-statement-row.row.income-tax-expense | 3.26 | -2.5 | 1.2 | 1.5 | ||||||||||||||
income-statement-row.row.net-income | -97.85 | -106.7 | -137.4 | -126.5 |
Pogosto zastavljeno vprašanje
Kaj je Hofseth BioCare ASA (HBC.OL) skupna sredstva?
Hofseth BioCare ASA (HBC.OL) skupna sredstva so 390119000.000.
Kakšen je letni prihodek podjetja?
Letni prihodki so 97985000.000.
Kolikšna je stopnja dobička podjetja?
Dobiček podjetja je 0.049.
Kakšen je prosti denarni tok podjetja?
Prosti denarni tok je -0.131.
Kolikšna je neto stopnja dobička podjetja?
Čista stopnja dobička je -0.488.
Kolikšni so skupni prihodki podjetja?
Celotni prihodki so -0.437.
Kaj je Hofseth BioCare ASA (HBC.OL) čisti dobiček (čisti dobiček)?
Čisti dobiček (čisti prihodek) je -106682000.000.
Kolikšen je skupni dolg podjetja?
Skupni dolg je 136789000.000.
Kolikšni so stroški poslovanja?
Stroški poslovanja so 71606000.000.
Kolikšno je število denarnih sredstev podjetja?
Denarna sredstva podjetja so 22155000.000.